News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
50,111 Results
Type
Article (1980)
Company Profile (4)
Press Release (48126)
Multimedia
Podcasts (6)
Webinars (1)
Section
Business (22083)
Career Advice (52)
Deals (3035)
Drug Delivery (6)
Drug Development (6476)
Employer Resources (11)
FDA (1134)
Job Trends (1534)
News (29859)
Policy (1749)
Tag
Academia (113)
Accelerated approval (13)
ADA (3)
Adcomms (4)
Allergies (16)
Alliances (1382)
ALS (18)
Alzheimer's disease (97)
Antibody-drug conjugate (ADC) (73)
Approvals (1333)
Artificial intelligence (41)
ASCO (49)
Autoimmune disease (42)
Automation (3)
Bankruptcy (6)
Best Places to Work (1423)
BIO (2)
Biosimilars (22)
BioSpace Insights (4)
Biotechnology (7)
Bispecific (1)
Bladder cancer (51)
Brain cancer (5)
Breast cancer (126)
Cancer (873)
Cardiovascular disease (79)
Career advice (49)
Career pathing (3)
CAR-T (25)
CDC (3)
CDMO (9)
Celiac Disease (1)
Cell therapy (81)
Cervical cancer (8)
Clinical research (6683)
Collaboration (123)
Company closure (2)
Compensation (97)
Complete response letters (8)
COVID-19 (144)
CRISPR (17)
C-suite (35)
Cystic fibrosis (6)
Data (1344)
Denatured (1)
Depression (15)
Dermatology (27)
Diabetes (74)
Diagnostics (509)
Digital health (6)
Diversity, equity & inclusion (6)
Drug discovery (18)
Drug pricing (25)
Drug shortages (1)
Duchenne muscular dystrophy (23)
Earnings (21396)
Editorial (2)
Employer resources (9)
Events (5173)
Executive appointments (41)
FDA (1836)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (80)
Gene editing (29)
Generative AI (2)
Gene therapy (56)
GLP-1 (126)
Government (255)
Grass and pollen (1)
Guidances (231)
Healthcare (1488)
Hematology (28)
HIV (12)
Huntington's disease (5)
IgA nephropathy (16)
Immunology and inflammation (25)
Immuno-oncology (9)
Indications (42)
Infectious disease (167)
Inflammatory bowel disease (16)
Influenza (7)
Intellectual property (10)
Interviews (10)
IPO (2314)
IRA (3)
Job creations (173)
Job search strategy (42)
JPM (2)
Kidney cancer (8)
Kidney disease (8)
Labor market (18)
Layoffs (43)
Legal (264)
Licensing (1)
Liver cancer (9)
Longevity (1)
Lung cancer (171)
Lymphoma (115)
Machine learning (2)
Management (2)
Manufacturing (77)
Marketing (1)
MASH (35)
Medical device (1234)
Medtech (1249)
Mergers & acquisitions (833)
Metabolic disorders (208)
mRNA (19)
Multiple sclerosis (14)
NASH (3)
Neurodegenerative disease (25)
Neuropsychiatric disorders (14)
Neuroscience (252)
NextGen: Class of 2026 (357)
Non-profit (228)
Now hiring (6)
Obesity (97)
Opinion (16)
Ovarian cancer (31)
Pain (25)
Pancreatic cancer (44)
Parkinson's disease (35)
Partnered (2)
Patents (40)
Patient recruitment (50)
Patient selection (2)
Peanut (8)
People (1152)
Peptides (2)
Pharmaceutical (2)
Pharmacy benefit managers (6)
Phase 1 (1421)
Phase 2 (2575)
Phase 3 (3160)
Pipeline (2480)
Policy (16)
Postmarket research (264)
Preclinical (367)
Press Release (4)
Prostate cancer (41)
Psychedelics (7)
Radiopharmaceuticals (33)
Rare diseases (129)
Real estate (166)
Recruiting (3)
Regulatory (1885)
Reports (14)
Research institute (118)
Resumes & cover letters (3)
Rett syndrome (4)
RSV (4)
Schizophrenia (34)
Series A (9)
Series B (5)
Sickle cell disease (24)
Special edition (5)
Spinal muscular atrophy (15)
Sponsored (1)
Startups (99)
State (1)
Stomach cancer (2)
Substance use disorders (1)
Supply chain (4)
Tariffs (10)
The Weekly (5)
Vaccines (101)
Venture capital (8)
Weight loss (63)
Women's health (16)
Worklife (3)
Date
Today (5)
Last 7 days (58)
Last 30 days (206)
Last 365 days (3625)
2026 (2658)
2025 (3676)
2024 (3832)
2023 (3880)
2022 (4530)
2021 (4310)
2020 (4125)
2019 (3423)
2018 (2656)
2017 (2133)
2016 (1669)
2015 (2182)
2014 (1605)
2013 (889)
2012 (985)
2011 (1079)
2010 (1019)
Location
Africa (30)
Alabama (5)
Arizona (21)
Asia (3054)
Australia (343)
California (1662)
Canada (407)
China (189)
Colorado (71)
Connecticut (68)
Delaware (126)
Europe (7472)
Florida (237)
Georgia (49)
Hawaii (2)
Idaho (5)
Illinois (144)
India (12)
Indiana (106)
Iowa (1)
Japan (133)
Kansas (2)
Kentucky (7)
Louisiana (15)
Maine (19)
Maryland (175)
Massachusetts (1163)
Michigan (40)
Minnesota (88)
Mississippi (1)
Missouri (19)
Montana (4)
Nebraska (1)
Nevada (5)
New Hampshire (21)
New Jersey (828)
New Mexico (6)
New York (477)
North Carolina (265)
North Dakota (6)
Northern California (861)
Ohio (75)
Oklahoma (1)
Oregon (3)
Pennsylvania (342)
Puerto Rico (2)
Rhode Island (1)
South America (72)
South Carolina (2)
Southern California (709)
Tennessee (30)
Texas (192)
United States (6351)
Utah (50)
Virginia (24)
Washington D.C. (16)
Washington State (170)
West Virginia (1)
Wisconsin (10)
50,111 Results for "34".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)
August 24, 2026
·
3 min read
Press Releases
IPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2026
August 24, 2026
·
1 min read
Press Releases
DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES
September 4, 2026
·
13 min read
Press Releases
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
August 17, 2026
·
5 min read
Press Releases
Teitur Trophics announces successful results from Phase I clinical trial of first-in-class Parkinson’s disease peptide TT-P34
September 10, 2026
·
4 min read
Press Releases
Auxilium Health Closes Oversubscribed $3.4 Million Seed Round to Advance Its Aer™ Biomaterial Platform
July 14, 2026
·
2 min read
Press Releases
Gero Reaches $34M in Equity Funding to Turn the Physics of Aging Into Medicines
June 17, 2026
·
5 min read
Press Releases
Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock
April 20, 2026
·
3 min read
Earnings
Novo Holdings’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
Total assets under management for Novo Holdings, Novo Nordisk’s controlling shareholder, fell by more than one-third last year. The report caps off a tumultuous year for the Novo group of companies.
March 12, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Biotechnology Market Accelerates Toward USD 6.34 Trillion by 2035 as AI, Gene Editing, and Advanced Biologics Reshape Global Healthcare
May 26, 2026
·
1 min read
1 of 5,012
Next
